CVA Family Office’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1K Buy
130
+26
+25% +$2.69K ﹤0.01% 948
2026
Q1
$10.1K Buy
104
+96
+1,200% +$9.85K ﹤0.01% 991
2025
Q4
$849 Hold
8
– – ﹤0.01% 1128
2025
Q3
$1.02K Hold
8
– – ﹤0.01% 1129
2025
Q2
$981 Hold
8
– – ﹤0.01% 1099
2025
Q1
$810 Hold
8
– – ﹤0.01% 1151
2024
Q4
$739 Hold
8
– – ﹤0.01% 1144
2024
Q3
$773 Hold
8
– – ﹤0.01% 1112
2024
Q2
$686 Buy
+8
New +$671 ﹤0.01% 1126
2022
Q2
– Sell
-107
Closed -$6K – 926
2022
Q1
$6K Hold
107
– – ﹤0.01% 746
2021
Q4
$6K Buy
+107
New +$5.52K ﹤0.01% 720

Other funds holding EHC

CVA Family Office's EHC Position: Q2 2026 in Review

CVA Family Office increased its Encompass Health (EHC) stake by 25% in Q2 2026, buying an estimated $2.69K and bringing the position to 130 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #948.

CVA Family Office first reported a position in EHC in Q4 2021 and has held it in 11 quarters since. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • CVA Family Office held 130 shares of Encompass Health worth $13.1K as of Q2 2026.
  • CVA Family Office bought 26 Encompass Health shares in Q2 2026, an estimated $2.69K.
  • Encompass Health made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #948 holding.
  • CVA Family Office first reported a position in Encompass Health in Q4 2021 and has held it in 11 quarters since.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.